| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/23/2007 | US7166572 12-benzyloxy-23-((1S)-2-benzyloxy-1-hydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydrox6-((1R)-1-hydroxy-ethyl)-20-hydroxymethyl-16-16]hexaazacyclohenicosin-9-yl]-12-methyltetradecanamide; echinocandin class with a substituent at the ornithine-5, homotyrosine-4 and ortho position; fungal infections |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166461 Animal growth regulator |
| 01/23/2007 | US7166310 Stable extract from Hypericum perforatum L., method for the production thereof and its use as a topical medicament |
| 01/23/2007 | US7166307 Herb medicine composition to be spread on sanitary napkin for female |
| 01/23/2007 | CA2329193C Process for synthesizing cox-2 inhibitors |
| 01/23/2007 | CA2289753C Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
| 01/23/2007 | CA2141106C Glycopeptide antibiotic derivatives |
| 01/18/2007 | WO2007009109A2 Antiviral compounds |
| 01/18/2007 | WO2007008674A1 Crystalline cefdinir hydrates |
| 01/18/2007 | WO2007008672A1 Crystalline cefdinir trihemihydrate |
| 01/18/2007 | WO2007008665A1 Composition and the use thereof for the treatment of viral infections |
| 01/18/2007 | WO2007007781A1 Novel use of processed product of blueberry leaf |
| 01/18/2007 | WO2007007399A1 Thiazole compound |
| 01/18/2007 | WO2007006712A2 Mycoplasma subunit vaccine |
| 01/18/2007 | WO2007006707A1 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors |
| 01/18/2007 | WO2007006101A1 Surface proteins of pasteurella multocida |
| 01/18/2007 | WO2006130500A3 Tigecycline and methods of preparing 9-aminominocycline |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006112694A3 Nutritional supplement with colostrum and epa or dha or gla |
| 01/18/2007 | WO2006099358A3 Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
| 01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
| 01/18/2007 | WO2006061723A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 01/18/2007 | WO2006042104A3 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 01/18/2007 | WO2006033756A3 Multiple rna polymerase iii promoter expression constructs |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015747 Respiratory syncytial virus replication inhibitors |
| 01/18/2007 | US20070015723 Antiviral oligonucleotides having a conserved G4 core sequence |
| 01/18/2007 | US20070015721 Hiv-gag codon-optimised dna vaccines |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015239 Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015197 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070014857 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014749 Novel base material for pharmaceutical and/or cosmetic cream (herbal composition for itchy or infected skin) |
| 01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
| 01/18/2007 | DE102005046474A1 Use of Aronia extract e.g. for the prevention or therapeutic treatment of bacterial disease, mycotic disease and/or inflammatory disease |
| 01/18/2007 | DE102005032781A1 Antibakterielle Amid-Markozyklen VII Antibacterial amide Marko cycles VII |
| 01/18/2007 | CA2614884A1 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 01/18/2007 | CA2614276A1 Antiviral compounds |
| 01/18/2007 | CA2614261A1 Mycoplasma subunit vaccine |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/18/2007 | CA2610210A1 1-[2' ,3'-dideoxy-3'c- (hydroxymethyl)- beta-d-erythro-pentofuranosyl cytosine derivatives as hiv inhibitors |
| 01/17/2007 | EP1743944A1 Novel method of screening |
| 01/17/2007 | EP1743942A1 Recombinant virus vector for gene introduction in lymphocyte |
| 01/17/2007 | EP1743903A2 Methods and compositions for treating disorders involving excitotoxicity |
| 01/17/2007 | EP1743891A1 Heterocyclic compounds and methods for modulating CXCR3 function |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743647A1 Antibacterial composition |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1742964A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 01/17/2007 | EP1742914A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/17/2007 | EP1742908A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/17/2007 | EP1742708A2 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 01/17/2007 | EP1742649A1 Active ingredient complex of seaweed plants, especially the zosteraceae family, method for the production thereof, and use of the same |
| 01/17/2007 | EP1742642A2 Phosphonate analogs of hiv integrase inhibitor compounds |
| 01/17/2007 | EP1542679B1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv |
| 01/17/2007 | EP1537117B1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents |
| 01/17/2007 | EP1504095B1 Site specific listeria integration vectors and methods for using the same |
| 01/17/2007 | EP1450762B1 Novel formulation |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1336612B1 Novel carbapenem derivatives |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 01/17/2007 | EP1170013B1 Drugs, foods, drinks and feeds containing cocoa component |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1094822B1 Water miscible azalide solutions |
| 01/17/2007 | EP1086207B1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 01/17/2007 | CN1898247A Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/17/2007 | CN1898238A Oxazolidinone-quinolone hybrid antibiotics |
| 01/17/2007 | CN1898231A Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 01/17/2007 | CN1897968A Method of treatment using interferon-tau |
| 01/17/2007 | CN1897958A Antiviral preparations obtained from a natural cinnamon extract |
| 01/17/2007 | CN1897954A Florfenicol prodrug having improved water solubility |
| 01/17/2007 | CN1896238A Genic engineering strain of expression recombinant prawn peptide Pen24 and its use |
| 01/17/2007 | CN1896107A Cecropin A-magainin hybrid gene engineering bactericidal peptide |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896077A Synthesis and purification of valacyclovir |
| 01/17/2007 | CN1895672A Multifunctional broad-spectrum obtundent of polyphyletic synergistic and its use |
| 01/17/2007 | CN1895669A Mucosa-immune composite adjuvant |
| 01/17/2007 | CN1895668A Composite mucosa immunoadjuvant for oral vaccine |
| 01/17/2007 | CN1895667A Reovirus inactivated vaccine and its preparation |
| 01/17/2007 | CN1895666A Cow mastitis concatenate inactivated vaccine |
| 01/17/2007 | CN1895657A Cough-curing beverage |
| 01/17/2007 | CN1895634A Tumeric root tuber externally-applied medicine |
| 01/17/2007 | CN1895632A Compound turmeric acne-eliminating gel and its preparation |
| 01/17/2007 | CN1895626A Chinese medicine for treating liver |
| 01/17/2007 | CN1895588A Pills for treating measles |
| 01/17/2007 | CN1895578A Chinese-medicinal syrup for treating epidemic bleeding |
| 01/17/2007 | CN1895538A Chinese-medicinal preparation for treating wet beriberi |
| 01/17/2007 | CN1895528A Dampness-removing ballets for treating tinea pedis |
| 01/17/2007 | CN1895519A Fumigant medicine for treating genital organs vesicle and its preparation |